Miyabe et al. demonstrated that the expression of LPAR1 in the synovium of RA patients was high, and in LPA1-/-mice or mice using LPA1 antagonists, inflammatory cell infiltration and joint destruction in bones were reduced. This evidence concerns the gene LPAR1 and rheumatoid arthritis.